Nature Technology Corp.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Nature Technology Corp.
BMS/bluebird and Janssen/Legend have the leading BCMA-targeting CAR-T therapies for multiple myeloma but Poseida, Allogene, CARsgen, Gracell and CBMG are emerging with novel approaches.
- Gene Therapy, Cell Therapy
- Nanotechnology, Chips, etc.
- Other Names / Subsidiaries